Literature DB >> 18188017

Airway modeling and remodeling in the pathogenesis of asthma.

Stephanie M Warner1, Darryl A Knight.   

Abstract

PURPOSE OF REVIEW: Asthma remains a severe health problem since current therapies are directed to suppressing, rather than preventing or reversing, the primary disease process. Clearly, a greater understanding of the pathogenesis of asthma is critical to the development of better therapeutic modalities. In this review, we discuss the recent advancements in research targeting the role of airway remodeling in asthma. RECENT
FINDINGS: Epithelial fragility and abnormalities are being recognized as important facets of asthma, as are other features of remodeling such as angiogenesis, goblet cell hyperplasia and thickened lamina reticularis. Significantly, these anomalies occur early in disease pathogenesis. However, their impact on disease severity remains unclear.
SUMMARY: Although an altered immune response is undoubtedly important to the pathogenesis of asthma, there is increasing evidence that the tissue-specific manifestations occur independently of inflammation and significantly impact on disease development and severity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18188017     DOI: 10.1097/ACI.0b013e3282f3b5cb

Source DB:  PubMed          Journal:  Curr Opin Allergy Clin Immunol        ISSN: 1473-6322


  23 in total

1.  Evaluation of furfuryl alcohol sensitization potential following dermal and pulmonary exposure: enhancement of airway responsiveness.

Authors:  Jennifer Franko; Laurel G Jackson; Ann Hubbs; Michael Kashon; B J Meade; Stacey E Anderson
Journal:  Toxicol Sci       Date:  2011-10-14       Impact factor: 4.849

2.  Human basophils express amphiregulin in response to T cell-derived IL-3.

Authors:  Yilin Qi; Darwin J Operario; Christopher M Oberholzer; James J Kobie; R John Looney; Steve N Georas; Tim R Mosmann
Journal:  J Allergy Clin Immunol       Date:  2010-10-30       Impact factor: 10.793

Review 3.  Airway wall remodeling in asthma: from the epithelial layer to the adventitia.

Authors:  Ynuk Bossé; Peter D Paré; Chun Y Seow
Journal:  Curr Allergy Asthma Rep       Date:  2008-07       Impact factor: 4.806

4.  Combinatorial ligand-directed lung targeting.

Authors:  Ricardo J Giordano; Julianna K Edwards; Rubin M Tuder; Wadih Arap; Renata Pasqualini
Journal:  Proc Am Thorac Soc       Date:  2009-08-15

5.  Functional expression of γ-amino butyric acid transporter 2 in human and guinea pig airway epithelium and smooth muscle.

Authors:  Sarah Zaidi; George Gallos; Peter D Yim; Dingbang Xu; Joshua R Sonett; Reynold A Panettieri; William Gerthoffer; Charles W Emala
Journal:  Am J Respir Cell Mol Biol       Date:  2010-11-05       Impact factor: 6.914

Review 6.  Metal nanomaterials: Immune effects and implications of physicochemical properties on sensitization, elicitation, and exacerbation of allergic disease.

Authors:  Katherine A Roach; Aleksandr B Stefaniak; Jenny R Roberts
Journal:  J Immunotoxicol       Date:  2019-12       Impact factor: 3.000

7.  Calcineurin/nuclear factor of activated T cells-coupled vanilliod transient receptor potential channel 4 ca2+ sparklets stimulate airway smooth muscle cell proliferation.

Authors:  Limin Zhao; Michelle N Sullivan; Marlee Chase; Albert L Gonzales; Scott Earley
Journal:  Am J Respir Cell Mol Biol       Date:  2014-06       Impact factor: 6.914

8.  Expression profiling identifies Klf15 as a glucocorticoid target that regulates airway hyperresponsiveness.

Authors:  Kiriko Masuno; Saptarsi M Haldar; Darwin Jeyaraj; Christina M Mailloux; Xiaozhu Huang; Rey A Panettieri; Mukesh K Jain; Anthony N Gerber
Journal:  Am J Respir Cell Mol Biol       Date:  2011-01-21       Impact factor: 6.914

9.  Pulmonary remodeling in asthma.

Authors:  Phil Lieberman
Journal:  F1000 Med Rep       Date:  2010-10-12

10.  Neutralisation of interleukin-13 in mice prevents airway pathology caused by chronic exposure to house dust mite.

Authors:  Kate L Tomlinson; Gareth C G Davies; Daniel J Sutton; Roger T Palframan
Journal:  PLoS One       Date:  2010-10-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.